每季打一针?美药厂开始新冠与流感混合疫苗临床试验
Vaccine-maker Novavax kicks off trial for combined Covid-19/flu jab - https://t.co/vRNDpIpI8s -
American vaccine-maker Novavax has started its early stage trial of a vaccine which combines an as-yet-unapproved Covid-19 shot with the company’s NanoFlu influenza jab.
... pic.twitter.com/UkKjeKwvAJ
— kashco.co.uk (@Kashco_co_uk) September 8, 2021
美国生技药厂诺瓦瓦克斯(Novavax)今天宣布,旗下由流感疫苗和COVID-19疫苗结合而成的新疫苗NanoFlu/NVX-CoV2373,已展开初期临床试验。
路透社报导,诺瓦瓦克斯先前指出,NanoFlu/NVX-CoV2373的临床前研究显示,这支疫苗不仅对于A型和B型流感能引起很强的免疫反应,对COVID-19(2019冠状病毒疾病)的SARS-CoV-2病毒也能产生防护力。
联合新闻 |